Drug Search Results
More Filters [+]

AMT-2003

Alternative Names: amt-2003, amt2003, amt 2003
Latest Update: 2013-03-20
Latest Update Note: Clinical Trial Update

Product Description

For Cancer Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Auron Healthcare
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for AMT-2003

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Genital Cancer, Female|Prostate Cancer|Gastrointestinal Cancer|Colorectal Cancer

Phase 2: Hepatocellular Carcinoma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

AMT/P2GI/001 Part I

P2

Terminated

Hepatocellular Carcinoma

2010-03-01

AMT/P2GI/001 Part III

P3

Terminated

Colorectal Cancer

2010-01-01

AMT/P2CA/001

P3

Terminated

Gastrointestinal Cancer|Prostate Cancer|Genital Cancer, Female

2010-01-01

Recent News Events

Date

Type

Title